GGrantIndex
← Leaderboards

Macrogenics, Inc.

Rockville, MD

Compare ↔
$44,718,095
Total funding
16
Grants

Funding over time

peak $10.8M · FY2006–21
$20M$15M$10M$5M$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21

Funding mix

By agency

NIH$44,718,095 · 16

By mechanism

N01$25,791,329 · 1
U01$8,560,329 · 2
R01$4,664,237 · 1
RC3$2,999,972 · 1
R43$1,400,000 · 10
R44$1,302,228 · 1

Investigators at Macrogenics, Inc.

Investigator-initiatedAll funding

InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).

Rising Stars

First grant in the last 5 yrs

Not enough data

Emerging Leaders

6–10 yrs in

Not enough data

All-Time

Most funded here, all years

1Leslie S Johnson$4,864,2373 gr2Paul Andrew Moore$2,999,9721 gr3Jeffrey B Stavenhagen$1,402,2282 gr4Jeffrey L Nordstrom$500,0001 gr5Larry Tjoelker$471,0182 gr6Christopher T Rankin$200,0002 gr7Michel Schummer$100,0001 gr8Priska Von Haller$100,0001 gr

Largest grants

DUAL AFFINITY RE-TARGETING (DART) MOLECULES FOR HIV-1 SUPPRESSION$10,790,360
N01 · FY2017 · AI
IGF::OT::IGF DUAL AFFINITY RE-TARGETING MOLECULES FOR HIV-1 SUPPRESSION$7,449,454
N01 · FY2015 · AI
DUAL AFFINITY RE-TARGETING (DART) MOLECULES FOR HIV-1 SUPPRESSION$6,287,950
N01 · FY2021 · AI
Development of a Novel Bi-Specific Antibody Based Therapeutic that Simultaneously$2,999,972
RC3 · FY2010 · AI
Cocktail of Neutralizing MAbs for Smallpox Prevention$1,975,114
U01 · FY2008 · AI
Cocktail of Neutralizing MAbs for Smallpox Prevention$1,847,366
U01 · FY2009 · AI
Cocktail of Neutralizing MAbs for Smallpox Prevention$1,531,637
U01 · FY2007 · AI
DUAL AFFINITY RE-TARGETING (DART) MOLECULES FOR HIV-1 SUPPRESSION$1,263,565
N01 · FY2018 · AI
A Pan-Dengue Virus Immunotherapeutic for Prevention and Treatment$1,262,889
R01 · FY2012 · AI
Discovery of new anti-bacteremia vaccines for anthrax$1,225,780
U01 · FY2004 · AI
A Pan-Dengue Virus Immunotherapeutic for Prevention and Treatment$1,197,162
R01 · FY2011 · AI
A Pan-Dengue Virus Immunotherapeutic for Prevention and Treatment$1,185,525
R01 · FY2013 · AI
Discovery of new anti-bacteremia vaccines for anthrax$1,112,995
U01 · FY2003 · AI
A Pan-Dengue Virus Immunotherapeutic for Prevention and Treatment$1,018,661
R01 · FY2010 · AI
Cocktail of Neutralizing MAbs for Smallpox Prevention$867,437
U01 · FY2006 · AI
Enhancement of the immune response by Fc modification$660,308
R44 · FY2003 · CA
Enhancement of the immune response by Fc modification$513,256
R44 · FY2004 · CA
Vaccine discovery for Burkholderia via protection screen$500,000
R43 · FY2003 · AI
Enhancement of the immune response by Fc modification$128,664
R44 · FY2004 · CA
Melanoma Proteins in Serum and Urine$100,000
R43 · FY2004 · CA